Trial Profile
A Phase 1B, Single Center, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Noribogaine in Opioid Dependent Participants Seeking to Discontinue Methadone Opioid Substitution Treatment (OST)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Noribogaine (Primary)
- Indications Opioid-related disorders
- Focus Adverse reactions; Pharmacodynamics
- Sponsors DemeRx
- 16 Dec 2016 New trial record
- 01 Nov 2016 Results published in the Clinical Pharmacology in Drug Development